Literature DB >> 18469003

Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53.

Sreerama Shetty1, Praveenkumar Shetty, Steven Idell, Thirunavukkarasu Velusamy, Yashodhar P Bhandary, Rashmi S Shetty.   

Abstract

H1299 lung carcinoma cells lacking p53 (p53-/-) express minimal amounts of plasminogen activator inhibitor-1 (PAI-1) protein as well as mRNA. p53(-/-) cells express highly unstable PAI-1 mRNA. Transfection of p53 in p53(-/-) cells enhanced PAI-1 expression and stabilized PAI-1 mRNA. On the contrary, inhibition of p53 expression by RNA silencing in non-malignant human lung epithelial (Beas2B) cells decreased basal as well as urokinase-type plasminogen activator-induced PAI-1 expression because of accelerated degradation of PAI-1 mRNA. Purified p53 protein specifically binds to the PAI-1 mRNA 3'-un-translated region (UTR), and endogenous PAI-1 mRNA forms an immune complex with p53. Treatment of purified p53 protein with anti-p53 antibody abolished p53 binding to the 3'-UTR of PAI-1 mRNA. The p53 binding region maps to a 70-nucleotide PAI-1 mRNA 3'-UTR sequence, and insertion of the p53-binding sequence into beta-globin mRNA destabilized the chimeric transcript. Deletion experiments indicate that the carboxyl-terminal region (amino acid residues 296-393) of p53 protein interacts with PAI-1 mRNA. These observations demonstrate a novel role for p53 as an mRNA-binding protein that regulates increased PAI-1 expression and stabilization of PAI-1 mRNA in human lung epithelial and carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469003      PMCID: PMC2443651          DOI: 10.1074/jbc.M710268200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

Authors:  Robert L Strausberg; Elise A Feingold; Lynette H Grouse; Jeffery G Derge; Richard D Klausner; Francis S Collins; Lukas Wagner; Carolyn M Shenmen; Gregory D Schuler; Stephen F Altschul; Barry Zeeberg; Kenneth H Buetow; Carl F Schaefer; Narayan K Bhat; Ralph F Hopkins; Heather Jordan; Troy Moore; Steve I Max; Jun Wang; Florence Hsieh; Luda Diatchenko; Kate Marusina; Andrew A Farmer; Gerald M Rubin; Ling Hong; Mark Stapleton; M Bento Soares; Maria F Bonaldo; Tom L Casavant; Todd E Scheetz; Michael J Brownstein; Ted B Usdin; Shiraki Toshiyuki; Piero Carninci; Christa Prange; Sam S Raha; Naomi A Loquellano; Garrick J Peters; Rick D Abramson; Sara J Mullahy; Stephanie A Bosak; Paul J McEwan; Kevin J McKernan; Joel A Malek; Preethi H Gunaratne; Stephen Richards; Kim C Worley; Sarah Hale; Angela M Garcia; Laura J Gay; Stephen W Hulyk; Debbie K Villalon; Donna M Muzny; Erica J Sodergren; Xiuhua Lu; Richard A Gibbs; Jessica Fahey; Erin Helton; Mark Ketteman; Anuradha Madan; Stephanie Rodrigues; Amy Sanchez; Michelle Whiting; Anup Madan; Alice C Young; Yuriy Shevchenko; Gerard G Bouffard; Robert W Blakesley; Jeffrey W Touchman; Eric D Green; Mark C Dickson; Alex C Rodriguez; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Yaron S N Butterfield; Martin I Krzywinski; Ursula Skalska; Duane E Smailus; Angelique Schnerch; Jacqueline E Schein; Steven J M Jones; Marco A Marra
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

2.  Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.

Authors:  C Y Chen; J D Oliner; Q Zhan; A J Fornace; B Vogelstein; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

3.  Urokinase receptor antagonists: discovery and application to in vivo models of tumor growth.

Authors:  R J Tressler; P A Pitot; J R Stratton; L D Forrest; S Zhuo; R J Drummond; S Fong; M V Doyle; L V Doyle; H Y Min; S Rosenberg
Journal:  APMIS       Date:  1999-01       Impact factor: 3.205

4.  The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.

Authors:  C M Swaisgood; E L French; C Noga; R H Simon; V A Ploplis
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 5.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

6.  Urokinase induces expression of its own receptor in Beas2B lung epithelial cells.

Authors:  S Shetty; S Idell
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

7.  Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium.

Authors:  Sushmita Ghosh; Tamra Mendoza; Luis A Ortiz; Gary W Hoyle; Cesar D Fermin; Arnold R Brody; Mitchell Friedman; Gilbert F Morris
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

8.  Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells.

Authors:  Sreerama Shetty; Khalil Bdeir; Douglas B Cines; Steven Idell
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

9.  Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.

Authors:  M A Olman; N Mackman; C L Gladson; K M Moser; D J Loskutoff
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  31 in total

1.  Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system.

Authors:  Yashodhar P Bhandary; Shwetha K Shetty; Amarnath S Marudamuthu; Margaret R Gyetko; Steven Idell; Mehrnaz Gharaee-Kermani; Rashmi S Shetty; Barry C Starcher; Sreerama Shetty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-02       Impact factor: 5.464

2.  Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury.

Authors:  Shwetha K Shetty; Yashodhar P Bhandary; Amarnath S Marudamuthu; Daniel Abernathy; Thirunavukkarasu Velusamy; Barry Starcher; Sreerama Shetty
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

3.  Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.

Authors:  Amarnath S Marudamuthu; Shwetha K Shetty; Yashodhar P Bhandary; Sophia Karandashova; Michael Thompson; Venkatachalem Sathish; Galina Florova; Taryn B Hogan; Christina M Pabelick; Y S Prakash; Yoshikazu Tsukasaki; Jian Fu; Mitsuo Ikebe; Steven Idell; Sreerama Shetty
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

4.  p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis.

Authors:  Shwetha K Shetty; Nivedita Tiwari; Amarnath S Marudamuthu; Bijesh Puthusseri; Yashodhar P Bhandary; Jian Fu; Jeffrey Levin; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2017-03-06       Impact factor: 4.307

5.  Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.

Authors:  Claude Lalou; Nathalie Scamuffa; Samia Mourah; Francois Plassa; Marie-Pierre Podgorniak; Nadem Soufir; Nicolas Dumaz; Fabien Calvo; Nicole Basset-Seguin; Abdel-Majid Khatib
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

6.  PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; J Andrew Carlson; Agnes Noel; Jean-Michel Foidart; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Oncol       Date:  2010-03-01       Impact factor: 4.375

7.  Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: an environmental pollutant and a tobacco smoke constituent.

Authors:  Kun-Ming Chen; Joseph B Guttenplan; Shang-Min Zhang; Cesar Aliaga; Timothy K Cooper; Yuan-Wan Sun; Joseph DelTondo; Wieslawa Kosinska; Arun K Sharma; Kun Jiang; Richard Bruggeman; Kwangmi Ahn; Shantu Amin; Karam El-Bayoumy
Journal:  Int J Cancer       Date:  2013-04-22       Impact factor: 7.396

8.  p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure.

Authors:  Nivedita Tiwari; Amarnath S Marudamuthu; Yoshikazu Tsukasaki; Mitsuo Ikebe; Jian Fu; Sreerama Shetty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

Review 9.  Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

Authors:  Rohan Samarakoon; Paul J Higgins
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

Review 10.  Mechanisms of the epithelial-mesenchymal transition by TGF-beta.

Authors:  Michael K Wendt; Tressa M Allington; William P Schiemann
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.